BTK V416L Recombinant Human Active Protein Kinase

Bruton's tyrosine kinase (BTK) plays a vital role in B-cell antigen receptor (BCR) signalling transduction pathway. BTK can be used for the study of lymphomas and autoimmune diseases. BTK has multiple mutants. BTK V416L Recombinant Human Active Protein Kinase is a recombinant BTK V416L protein that can be used to study BTK V416L-related functions[1].

Product Specifications

UNSPSC

12352211

Target

Btk

Related Pathways

Protein Tyrosine Kinase/RTK

Field of Research

Cancer; Inflammation/Immunology

Smiles

[BTKV416LRecombinantHumanActiveProteinKinase]

References & Citations

[1]Das D, et al. Next-generation Bruton's Tyrosine Kinase (BTK) Inhibitors Potentially Targeting BTK C481S Mutation- Recent Developments and Perspectives. Curr Top Med Chem. 2022;22 (20) :1674-1691.